|
TAF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.42237349570951E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.42534897615587E-13 |
| Normal-vs-Stage2 |
1.04359999530956E-08 |
| Normal-vs-Stage3 |
1.092280E-02 |
| Normal-vs-Stage4 |
1.474620E-01 |
| Stage1-vs-Stage2 |
8.601600E-01 |
| Stage1-vs-Stage3 |
5.262300E-02 |
| Stage1-vs-Stage4 |
3.511800E-01 |
| Stage2-vs-Stage3 |
7.693700E-02 |
| Stage2-vs-Stage4 |
4.670400E-01 |
| Stage3-vs-Stage4 |
8.072600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67310609811011E-13 |
| Normal-vs-AfricanAmerican |
2.839499999574E-07 |
| Normal-vs-Asian |
3.566800E-01 |
| Caucasian-vs-AfricanAmerican |
3.536000E-01 |
| Caucasian-vs-Asian |
2.747600E-01 |
| AfricanAmerican-vs-Asian |
4.537400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63136171238421E-12 |
| Normal-vs-Female |
4.936500E-03 |
| Male-vs-Female |
4.647900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.2100000003108E-07 |
| Normal-vs-Extreme_Weight |
4.93605156748345E-13 |
| Normal-vs-Obese |
1.80714999999942E-05 |
| Normal-vs-Extreme_Obese |
3.37960004426208E-09 |
| Normal_Weight-vs-Extreme_Weight |
4.477400E-01 |
| Normal_Weight-vs-Obese |
2.078600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.922810E-01 |
| Extreme_Weight-vs-Obese |
1.799970E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.826200E-01 |
| Obese-vs-Extreme_Obese |
1.451680E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.670800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.43620000003786E-07 |
| Normal-vs-Age(61-80Yrs) |
1.62592161956354E-12 |
| Normal-vs-Age(81-100Yrs) |
2.86729973097977E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.814400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.920470E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.396400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.896700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.899200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.957440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63669078290241E-12 |
| Normal-VS-Type2 PRCC |
7.03989977424158E-10 |
| Normal-VS-KIRP CIMP |
1.439650E-01 |
| Normal-VS-Unclassified PRCC |
9.992700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.121400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.44250000225321E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
6.306500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.15040000001365E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
2.211000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.383920E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.99695856809512E-12 |
| Normal-vs-N1 |
4.192200E-01 |
| Normal-vs-N2 |
3.743600E-01 |
| N0-vs-N1 |
8.438500E-03 |
| N0-vs-N2 |
2.207800E-01 |
| N1-vs-N2 |
6.496200E-01 |
|
|
